Consistent with this finding, Gdpd3−/− tet-CML mice developed CML disease more rapidly than Gdpd3+/+ tet-CML mice, usually within three months of CML induction by Dox withdrawal (Fig. 1g). Here, GDPD3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.